Vanguard Group’s Pulmatrix PULM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $105K | Sell |
47,082
-2,327
| -5% | -$10.1K | ﹤0.01% | 4170 |
|
|
2025
Q3 | $241K | Buy |
49,409
+2,400
| +5% | +$12.7K | ﹤0.01% | 4097 |
|
|
2025
Q2 | $325K | Buy |
47,009
+4,607
| +11% | +$31.7K | ﹤0.01% | 4009 |
|
|
2025
Q1 | $282K | Buy |
42,402
+7,320
| +21% | +$53.8K | ﹤0.01% | 4001 |
|
|
2024
Q4 | $245K | Hold |
35,082
| – | – | ﹤0.01% | 4069 |
|
|
2024
Q3 | $75.1K | Hold |
35,082
| – | – | ﹤0.01% | 4220 |
|
|
2024
Q2 | $67.7K | Hold |
35,082
| – | – | ﹤0.01% | 4267 |
|
|
2024
Q1 | $61.4K | Hold |
35,082
| – | – | ﹤0.01% | 4291 |
|
|
2023
Q4 | $65.3K | Buy |
35,082
+13,548
| +63% | +$25.9K | ﹤0.01% | 4348 |
|
|
2023
Q3 | $43.7K | Buy |
21,534
+144
| +0.7% | +$355 | ﹤0.01% | 4423 |
|
|
2023
Q2 | $57.3K | Sell |
21,390
-20,294
| -49% | -$57.1K | ﹤0.01% | 4445 |
|
|
2023
Q1 | $122K | Sell |
41,684
-5,587
| -12% | -$20.2K | ﹤0.01% | 4383 |
|
|
2022
Q4 | $183K | Buy |
47,271
+58
| +0.1% | +$210 | ﹤0.01% | 4323 |
|
|
2022
Q3 | $169K | Sell |
47,213
-35,244
| -43% | -$157K | ﹤0.01% | 4439 |
|
|
2022
Q2 | $378K | Buy |
82,457
+1
| +0% | +$5 | ﹤0.01% | 4355 |
|
|
2022
Q1 | $563K | Sell |
82,456
-19,487
| -19% | -$141K | ﹤0.01% | 4374 |
|
|
2021
Q4 | $892K | Sell |
101,943
-436
| -0.4% | -$5.96K | ﹤0.01% | 4292 |
|
|
2021
Q3 | $1.64M | Hold |
102,379
| – | – | ﹤0.01% | 4119 |
|
|
2021
Q2 | $2.13M | Buy |
102,379
+15,164
| +17% | +$307K | ﹤0.01% | 3954 |
|
|
2021
Q1 | $2.32M | Buy |
87,215
+8,338
| +11% | +$255K | ﹤0.01% | 3830 |
|
|
2020
Q4 | $1.88M | Sell |
78,877
-1,244
| -2% | -$29.6K | ﹤0.01% | 3677 |
|
|
2020
Q3 | $1.91M | Buy |
80,121
+1,681
| +2% | +$42.8K | ﹤0.01% | 3501 |
|
|
2020
Q2 | $2.7M | Buy |
78,440
+70,565
| +896% | +$2.24M | ﹤0.01% | 3346 |
|
|
2020
Q1 | $159K | Buy |
7,875
+2,595
| +49% | +$75.7K | ﹤0.01% | 3892 |
|
|
2019
Q4 | $91K | Hold |
5,280
| – | – | ﹤0.01% | 4015 |
|
|
2019
Q3 | $86K | Buy |
5,280
+898
| +20% | +$15.7K | ﹤0.01% | 4046 |
|
|
2019
Q2 | $81K | Buy |
4,382
+913
| +26% | +$19.9K | ﹤0.01% | 4068 |
|
|
2019
Q1 | $88K | Buy |
3,469
+496
| +17% | +$16.6K | ﹤0.01% | 4022 |
|
|
2018
Q4 | $143K | Sell |
2,973
-102
| -3% | -$7.52K | ﹤0.01% | 3945 |
|
|
2018
Q3 | $228K | Sell |
3,075
-187
| -6% | -$15.9K | ﹤0.01% | 3985 |
|
|
2018
Q2 | $294K | Buy |
3,262
+1,313
| +67% | +$128K | ﹤0.01% | 3924 |
|
|
2018
Q1 | $198K | Buy |
1,949
+807
| +71% | +$232K | ﹤0.01% | 3954 |
|
|
2017
Q4 | $323K | Buy |
1,142
+575
| +101% | +$195K | ﹤0.01% | 3843 |
|
|
2017
Q3 | $232K | Buy |
567
+68
| +14% | +$27.7K | ﹤0.01% | 3887 |
|
|
2017
Q2 | $240K | Buy |
499
+37
| +8% | +$20K | ﹤0.01% | 3872 |
|
|
2017
Q1 | $323K | Buy |
462
+390
| +542% | +$232K | ﹤0.01% | 3827 |
|
|
2016
Q4 | $8K | Sell |
72
-65
| -47% | -$12.8K | ﹤0.01% | 4074 |
|
|
2016
Q3 | $45K | Buy |
137
+36
| +36% | +$13.5K | ﹤0.01% | 4039 |
|
|
2016
Q2 | $40K | Hold |
101
| – | – | ﹤0.01% | 4092 |
|
|
2016
Q1 | $58K | Hold |
101
| – | – | ﹤0.01% | 4066 |
|
|
2015
Q4 | $79K | Buy |
+101
| New | +$91.3K | ﹤0.01% | 4101 |
|
Other funds holding PULM
SS
DS
TRCT
FHA
Vanguard Group's PULM Position: Q4 2025 in Review
Vanguard Group reduced its Pulmatrix (PULM) stake by 4.7% in Q4 2025, selling an estimated $10.1K and leaving 47,082 shares worth $105K. The position accounts for ﹤0.01% of the portfolio, ranked #4170.
Vanguard Group first reported a position in PULM in Q4 2015 and has held it in 41 quarters since. The position peaked at $2.7M in Q2 2020. 15 funds tracked by Wall St. Rank hold PULM as of Q4 2025.
- Vanguard Group held 47,082 shares of Pulmatrix worth $105K as of Q4 2025.
- Vanguard Group sold 2,327 Pulmatrix shares in Q4 2025, an estimated $10.1K.
- Pulmatrix made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #4170 holding.
- Vanguard Group first reported a position in Pulmatrix in Q4 2015 and has held it in 41 quarters since.
- Vanguard Group's Pulmatrix position peaked at $2.7M in Q2 2020.
- 15 funds tracked by Wall St. Rank held Pulmatrix as of Q4 2025.
Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.